120 related articles for article (PubMed ID: 8358252)
1. Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.
Antoniazzi F; Radetti G; Zamboni G; Gambaro G; Adami S; Tatò L
Bone Miner; 1993 May; 21(2):151-6. PubMed ID: 8358252
[TBL] [Abstract][Full Text] [Related]
2. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone therapy on bone metabolism of growth hormone deficient children.
Stamoyannou L; Karachaliou F; Gioureli E; Voskaki E; Mengreli C; Bartsocas CS; Koutselinis A
Eur J Pediatr; 1997 Aug; 156(8):592-6. PubMed ID: 9266187
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human growth hormone replacement therapy and bone metabolism in children.
Zamboni G; Antoniazzi F; Tatò L
J Pediatr Endocrinol; 1993; 6(1):33-7. PubMed ID: 8374686
[TBL] [Abstract][Full Text] [Related]
6. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
7. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures.
Chenu C; Valentin-Opran A; Chavassieux P; Saez S; Meunier PJ; Delmas PD
Bone; 1990; 11(2):81-6. PubMed ID: 2357426
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
[TBL] [Abstract][Full Text] [Related]
10. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
11. Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvariae.
Lian JB; Coutts M; Canalis E
J Biol Chem; 1985 Jul; 260(15):8706-10. PubMed ID: 3894347
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment.
Antoniazzi F; Bertoldo F; Zamboni G; Valentini R; Sirpresi S; Cavallo L; Adami S; Tatò L
Eur J Endocrinol; 1995 Oct; 133(4):412-7. PubMed ID: 7581963
[TBL] [Abstract][Full Text] [Related]
13. Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.
Gundberg CM; Cole DE; Lian JB; Reade TM; Gallop PM
J Clin Endocrinol Metab; 1983 May; 56(5):1063-7. PubMed ID: 6601111
[TBL] [Abstract][Full Text] [Related]
14. Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.
Miki T; Nakatsuka K; Nishizawa Y; Emoto M; Morita A; Tabata T; Matsushita Y; Inoue T; Morii H
Endocrinol Jpn; 1991 Oct; 38(5):479-83. PubMed ID: 1843267
[TBL] [Abstract][Full Text] [Related]
15. Effects of porcine sometotropin on calcium and phosphorus balance and markers of bone metabolism in finishing pigs.
Carter SD; Cromwell GL; Colombo G; Fanti P
J Anim Sci; 1999 Aug; 77(8):2163-71. PubMed ID: 10461995
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy.
Balducci R; Toscano V; Pasquino AM; Mangiantini A; Municchi G; Armenise P; Terracina S; Prossomariti G; Boscherini B
Eur J Endocrinol; 1995 Jan; 132(1):42-6. PubMed ID: 7850009
[TBL] [Abstract][Full Text] [Related]
18. Mineral metabolism in obese children.
Zamboni G; Soffiati M; Giavarina D; Tató L
Acta Paediatr Scand; 1988 Sep; 77(5):741-6. PubMed ID: 2849283
[TBL] [Abstract][Full Text] [Related]
19. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids.
Sanchez CP; Goodman WG; Brandli D; Goldenhersh M; Murray C; Carlton E; Hahn T; Salusky IB
J Bone Miner Res; 1995 Jan; 10(1):2-6. PubMed ID: 7747627
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
Kotzmann H; Riedl M; Bernecker P; Clodi M; Kainberger F; Kaider A; Woloszczuk W; Luger A
Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
